These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10675688)

  • 21. Dynamic changes in size distribution of emulsion droplets during ethyl acetate-based microencapsulation process.
    Bahl Y; Sah H
    AAPS PharmSciTech; 2000 Mar; 1(1):E5. PubMed ID: 14727854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.
    Yang YY; Chia HH; Chung TS
    J Control Release; 2000 Oct; 69(1):81-96. PubMed ID: 11018548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods.
    Herrmann J; Bodmeier R
    Eur J Pharm Biopharm; 1998 Jan; 45(1):75-82. PubMed ID: 9689538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size.
    Shiga K; Muramatsu N; Kondo T
    J Pharm Pharmacol; 1996 Sep; 48(9):891-5. PubMed ID: 8910847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of new reverse micellar microencapsulation technique to load water-soluble drug into PLGA microspheres.
    Kim H; Cho M; Sah H
    Arch Pharm Res; 2005 Mar; 28(3):370-5. PubMed ID: 15832828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The formation and characterization of hydrocortisone-loaded poly((+/-)-lactide) microspheres.
    Cavalier M; Benoit JP; Thies C
    J Pharm Pharmacol; 1986 Apr; 38(4):249-53. PubMed ID: 2872287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ammonolysis-induced solvent removal: a facile approach for solidifying emulsion droplets into PLGA microspheres.
    Kim J; Hong D; Chung Y; Sah H
    Biomacromolecules; 2007 Dec; 8(12):3900-7. PubMed ID: 18031011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of solvent/non-solvent ratio on microsphere formation using the solvent removal method.
    Godbee J; Scott E; Pattamunuch P; Chen S; Mathiowitz E
    J Microencapsul; 2004 Mar; 21(2):151-60. PubMed ID: 15198427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applicability of non-halogenated methyl propionate to microencapsulation.
    Kang J; Sah E; Sah H
    J Microencapsul; 2014; 31(4):323-32. PubMed ID: 24175715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of different formulations and process parameters during the preparation of drug-loaded PLGA microspheres evaluated by multivariate data analysis.
    Vysloužil J; Doležel P; Kejdušová M; Mašková E; Mašek J; Lukáč R; Košťál V; Vetchý D; Dvořáčková K
    Acta Pharm; 2014 Dec; 64(4):403-17. PubMed ID: 25531782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of insulin-loaded PLA/PLGA microcapsules by a novel membrane emulsification method and its release in vitro.
    Liu R; Huang SS; Wan YH; Ma GH; Su ZG
    Colloids Surf B Biointerfaces; 2006 Aug; 51(1):30-8. PubMed ID: 16814994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethyl acetate as a dispersing solvent in the production of poly(DL-lactide-co-glycolide) microspheres: effect of process parameters and polymer type.
    Soppimath KS; Aminabhavi TM
    J Microencapsul; 2002; 19(3):281-92. PubMed ID: 12022494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
    Fu X; Ping Q; Gao Y
    J Microencapsul; 2005 Feb; 22(1):57-66. PubMed ID: 16019891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization.
    O'Hara P; Hickey AJ
    Pharm Res; 2000 Aug; 17(8):955-61. PubMed ID: 11028941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preparation of sustained release microspheres containing oxymatrine and their release characteristics in vitro].
    Miao Y; Shen XC; Xiao CD; Wu LF; Zhou X; Tao L
    Zhong Yao Cai; 2012 Oct; 35(10):1674-9. PubMed ID: 23627137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An improvement of double emulsion technique for preparing bovine serum albumin-loaded PLGA microspheres.
    Zhang JX; Zhu KJ
    J Microencapsul; 2004 Nov; 21(7):775-85. PubMed ID: 15799227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PLGA microspheres with high drug loading and high encapsulation efficiency prepared by a novel solvent evaporation technique.
    Bao W; Zhou J; Luo J; Wu D
    J Microencapsul; 2006 Aug; 23(5):471-9. PubMed ID: 16980270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics.
    Rawat A; Burgess DJ
    Int J Pharm; 2010 Jul; 394(1-2):99-105. PubMed ID: 20472046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emulsion spray-drying for the preparation of albumin-loaded PLGA microspheres.
    Giunchedi P; Conti B; Genta I; Conte U; Puglisi G
    Drug Dev Ind Pharm; 2001 Aug; 27(7):745-50. PubMed ID: 11694022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.